January - 2019

Daunorubicin reduces cardiomyopathy risk compared with doxorubicin in childhood cancer survivors

Daunorubicin appeared associated with a lower cardiomyopathy risk than doxorubicin among childhood cancer survivors, according to a...

International Research Team Led by Australian Scientists Discover a Potential Way to Treat and Preve

Discovering this link – by which MYCN controls polyamine levels in cancer cells, driving the growth and proliferation of the...

Cancer-slaying virus may fight childhood eye tumor

Curing the childhood eye cancer retinoblastoma often comes at a cost. The tumor, which sprouts in the retina and primarily occurs in...

New tumor test could guide personalized treatment for children with cancer

Scientists at the University of British Columbia and BC Children's Hospital are the first in Canada to use a new test for pediatric...

Engineered immune cells target broad range of pediatric solid tumors in mice

In mouse studies, a Stanford-led team has developed an engineered immune cell that eliminates several types of childhood tumors. The...

Researchers identify multiple new subtypes of most common childhood cancer

Researchers used integrated genomic analysis, including RNA sequencing, to define the genomic landscape of B-cell acute lymphoblastic...

What Price Do Families Pay When a Child has Cancer?

New research by POGO is linking data from its cancer registry (POGONIS) to copies of Canadian tax returns stored at Statistics Canada....

Cardiotoxic childhood cancer treatment boosts heart failure risk at young age

Childhood cancer survivors who received cardiotoxic treatment are at high risk of heart failure at a young age, researchers say. Read...

What is to blame for childhood cancer? We often misunderstand the reality

A new study by UNSW medical researchers sheds light on an understudied area – community beliefs about what causes cancer in children....

Lead Researcher Highlights Tisagenlecleucel Benefit in Younger Leukemia Patients

The CD19-targeted CAR T-cell therapy, tisagenlecleucel (Kymriah) demonstrated durable remissions in pediatric and young adult patients...

1

Pediatric Cancer Survivors Treated With Abdominopelvic RT Have Higher Risk of CRC

Study shows potential of new treatment strategies for most common childhood cancer

Promising target for CAR T cells helps cancer trick the immune system

Palliative Care Important for Young Patients During ‘Identity Development’

Scientists discover new Achilles heel of leukemia cells

Promising investigational therapy improves survival in aggressive childhood brain tumor

Childhood cancer mortality has fallen significantly in the US, but disparities have emerged

St. Jude scientists identify T-cell differentiation nodes to improve cancer-killing

Analysis shows high rate of ‘significant’ health problems in childhood cancer survivors

Fusion oncoprotein forces cell fates toward rhabdomyosarcoma